Danske Bank A/S
Danske Bank share buy-back programme: transactions in week 46
Danske Bank share buy-back programme: transactions in week 46
| Company announcement no. 51 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 33 44 00 00 17 November 2025 Page 1 of 1 Danske Bank share buy-back programme: transactions in week 46 On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025. The Programme is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 (the "Market Abuse Regulation") and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the "Safe Harbour Rules"). The following transactions on Nasdaq Copenhagen A/S were made under the share buy-back programme in week 46: |
| Number of shares | VWAP DKK | Gross value DKK | |
| Accumulated, last announcement | 15,228,475 | 248.7162 | 3,787,567,968 |
| 10 November 2025 | 39,000 | 293.4562 | 11,444,792 |
| 11 November 2025 | 39,000 | 297.1858 | 11,590,246 |
| 12 November 2025 | 38,000 | 301.3057 | 11,449,617 |
| 13 November 2025 | 15,000 | 301.3116 | 4,519,674 |
| 14 November 2025 | 80,000 | 295.6892 | 23,655,136 |
| Total accumulated over week 46 | 211,000 | 296.9643 | 62,659,465 |
| Total accumulated during the share buyback programme | 15,439,475 | 249.3755 | 3,850,227,432 |
With the transactions stated above, the total accumulated number of own shares under the share buy-back programme corresponds to 1.849% of Danske Bank A/S' share capital. Danske Bank Contact: Claus Ingar Jensen, Head of Group Investor Relations, tel. +45 25 42 43 70 |
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.17.11.2025 12:00:00 CET | Press release
High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
Zymeworks Inc.17.11.2025 12:00:00 CET | Press release
Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
Verkkokauppa.com Oyj17.11.2025 12:00:00 CET | Press release
Change in Verkkokauppa.com’s Management Team: Tatu Kaleva resigns to take on a new role with another company
Royal UNIBREW A/S17.11.2025 11:29:20 CET | Press release
Share buy-back program
Brunswick Exploration17.11.2025 11:00:00 CET | Press release
Brunswick Exploration Drills 47.2 Meters at 1.66% Li2O Within 120.7 Meters at 1.31% Li2O
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom